CPMG Inc, Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 27,200 shares at $26.10 ($705K) on 2017-12-28, disclosed to the SEC on 2017-12-28.
Open-market purchase of $705k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.06 | 12,000 | $313K | 44.3% |
| 2 | $25.83 | 15,000 | $387K | 54.9% |
| 3 | $26.10 | 200 | $5K | 0.7% |
| Total | $25.93 avg | 27,200 | $705K | 100% |
| Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |
| RETA | BUY | 2018-12-12 | $13.2M | — | Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |